Series D funding round for Eikon Therapeutics raising $350M in February 2025
Series D funding round for Eikon Therapeutics raising $350M in February 2025
| Investor | Firm Type | Partner |
|---|
Lux CapitalLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Carol Gallagher |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$1.1B
Top Valuation
-
Eikon Therapeutics raised $350M in a Series D round.
The round was announced on 02/01/25.
The round was led by Lux Capital.